PANTHERx selected by Otsuka to distribute Jynarque
PITTSBURGH — PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD). PANTHERx is one of just three pharmacies providing nationwide access to the medication. ADPKD is one of the most common, life-threatening genetic diseases, diagnosed
